1-5 of 5
Elizabeth A. Maher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

Open Access
Ingo K. Mellinghoff, Marta Penas-Prado, Katherine B. Peters, Howard A. Burris, III, Elizabeth A. Maher, Filip Janku, Gregory M. Cote, Macarena I. de la Fuente, Jennifer L. Clarke, Benjamin M. Ellingson, Saewon Chun, Robert J. Young, Hua Liu, Sung Choe, Min Lu, Kha Le, Islam Hassan, Lori Steelman, Shuchi S. Pandya, Timothy F. Cloughesy, Patrick Y. Wen
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (16): 4491–4499.
https://doi.org/10.1158/1078-0432.CCR-21-0611
Published: 15 August 2021
View articletitled, Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Open the PDF for Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial in another window
Includes: Supplementary data
Journal Articles

Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma

Available to Purchase
Peter B. Dirks, Mark R. Gilbert, Eric C. Holland, Elizabeth A. Maher, William A. Weiss
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11): 2457–2460.
https://doi.org/10.1158/1078-0432.CCR-19-3924
Published: 01 June 2020
View articletitled, Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma
Open the PDF for Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma in another window
Journal Articles

The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth

Free
Calin O. Marian, Steve K. Cho, Brian M. Mcellin, Elizabeth A. Maher, Kimmo J. Hatanpaa, Christopher J. Madden, Bruce E. Mickey, Woodring E. Wright, Jerry W. Shay, Robert M. Bachoo
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (1): 154–163.
https://doi.org/10.1158/1078-0432.CCR-09-2850
Published: 04 January 2010
View articletitled, The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth
Open the PDF for The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth in another window
Includes: Supplementary data
Journal Articles

Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

Free
Patrick Y. Wen, W.K. Alfred Yung, Kathleen R. Lamborn, Patricia L. Dahia, Yanfeng Wang, Bin Peng, Lauren E. Abrey, Jeffrey Raizer, Timothy F. Cloughesy, Karen Fink, Mark Gilbert, Susan Chang, Larry Junck, David Schiff, Frank Lieberman, Howard A. Fine, Minesh Mehta, H. Ian Robins, Lisa M. DeAngelis, Morris D. Groves, Vinay K. Puduvalli, Victor Levin, Charles Conrad, Elizabeth A. Maher, Kenneth Aldape, Michael Hayes, Laurie Letvak, Merrill J. Egorin, Renaud Capdeville, Richard Kaplan, Anthony J. Murgo, Charles Stiles, Michael D. Prados
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (16): 4899–4907.
https://doi.org/10.1158/1078-0432.CCR-06-0773
Published: 16 August 2006
View articletitled, Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08
Open the PDF for Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08 in another window
Journal Articles

A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening

Free
Pasi A. Jänne, Ana M. Borras, Yanan Kuang, Andrew M. Rogers, Victoria A. Joshi, Hema Liyanage, Neal Lindeman, Jeffrey C. Lee, Balazs Halmos, Elizabeth A. Maher, Robert J. Distel, Matthew Meyerson, Bruce E. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (3): 751–758.
https://doi.org/10.1158/1078-0432.CCR-05-2047
Published: 07 February 2006
View articletitled, A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening
Open the PDF for A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening in another window